The Retina Health Market growth continues to accelerate as age-related macular degeneration remains the leading cause of irreversible vision loss in older adults across developed and developing nations. With the global population over 60 projected to double by 2050 and AMD affecting approximately 170 million people worldwide, the demand for anti-VEGF therapy for neovascular AMD, complement...